CRH-like peptides in human reproduction

Current Medicinal Chemistry

Volumn 16, Issue 32, 2009, Pages 4230-4235

  Zoumakis, E ^a   Kalantaridou, S N ^b   Makrigiannakis, A ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Antalarmin; CRH; Decidualization; Implantation; Stresscopin; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; UROCORTIN I; UROCORTIN II; UROCORTIN III;

DECIDUALIZATION; ENDOMETRIUM CELL; FEMALE GENITAL SYSTEM; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; IMMUNOREACTIVITY; LABOR; NONHUMAN; OVARY CELL; PEPTIDE ANALYSIS; PLACENTA; PREGNANCY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPRODUCTION; REVIEW; SPONTANEOUS ABORTION; STEROIDOGENESIS; TROPHOBLAST;

AMINO ACID SEQUENCE; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; PREGNANCY; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REPRODUCTION; UROCORTINS;

EID: 70450189741     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789578204     Document Type: Review

References (66)

1. Raux-Demay, M.C.; Girard, F. The physiology of corticotropin-releasing factor (CRF). Reprod. Nutr. Dev., 1985, 25, 931-943.
2. Orth, D.N. Corticotropin-releasing hormone in humans. Endocr. Rev., 1992, 13, 164-191.
3. Suda, T.; Tomori, N.; Tozawa, F.; Mouri, T.; Demura, H.; Shizume, K. Distribution and characterization of immunoreactive corticotropin- releasing factor in human tissues. J. Clin. Endocrinol. Metab., 1984, 59, 861-866.
4. Usui, T.; Nakai, Y.; Tsukada, T.; Jingami, H.; Takahashi, H.; Fukata, J.; Imura, H. Expression of adrenocorticotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol. Endocrinol., 1988, 2, 871-875. (Pubitemid 18216133)
5. Gallagher, J.P.; Orozco-Cabal, L.F.; Liu, J.; Shinnick-Gallagher, P. Synaptic physiology of central CRH system. Eur. J. Pharmacol., 2008, 583, 215-225 .
6. Dautzenberg, F.M.; Hauger, R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci., 2002, 23, 71-77.
7. Grammatopoulos, D.K.; Chrousos, G.P. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol. Metab., 2002, 13, 436-444.
8. Teli, T.; Markovic, D.; Levine, M.A.; Hillhouse, E.W.; Grammatopoulos, D.K. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol. Endocrinol., 2005, 19, 474-490.
9. Punn, A.; Levine, M.A.; Grammatopoulos, D.K. Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation. Mol. Endocrinol., 2006, 20, 3179-3195.
10. Pisarchik, A.; Slominski, A.T. Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB. J., 2001, 15, 2754-2756.
11. Zoumakis, E.; Rice, K.C.; Gold, P.W.; Chrousos, G.P. Potential uses of corticotropin-releasing hormone antagonists. Ann. N. Y. Acad. Sci., 2006, 1083, 239-251. (Pubitemid 44955476)
12. Hillhouse, E.W.; Grammatopoulos, D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin- releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev., 2006, 27, 260-286 .
13. Arai, M.; Assil, I.Q.; Abou-Samra, A.B. Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis. Endocrinology, 2001, 142, 446-454.
14. Xiong, Y.; Xie, L.Y.; Abou-Samra, A.B. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor. Endocrinology, 1995, 136, 1828-1834.
15. Grigoriadis, D.E.; Heroux, J.A.; De Souza, E.B. Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems. Ciba. Found. Symp., 1993, 172, 85-101.
16. Bale, T.L.; Vale, W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol., 2004, 44, 525-557.
17. Slominski, A.; Wortsman, J.; Luger, T.; Paus, R.; Solomon, S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev., 2000, 80, 979-1020. (Pubitemid 30452009)
18. Slominski, A.; Zbytek, B.; Zmijewski, M.; Slominski, R.M.; Kauser, S.; Wortsman, J.; Tobin, D.J. Corticotropin releasing hormone and the skin. Front. Biosci., 2006, 1, 2230-2248 .
19. Slominski, A.; Wortsman. J.; Tuckey, R.C.; Paus, R. Differential expression of HPA axis homolog in the skin. Mol. Cell. Endocrinol., 2007, 265-266, 143-149. (Pubitemid 46273958)
20. Tsigos, C.; Chrousos, G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res., 2002, 53, 865-871.
21. Vitoratos, N.; Papatheodorou, D.C.; Kalantaridou, S.N.; Mastorakos, G. "Reproductive" corticotropin-releasing hormone. Ann. N. Y. Acad. Sci., 2006, 1092, 310-318.
22. Westphal, N.J.; Seasholtz, A.F. CRH-BP: the regulation and function of a phylogenetically conserved binding protein. Front. Biosci., 2006, 11, 1878-1891. (Pubitemid 43253401)
23. Ghizzoni, L.; Mastorakos, G.; Vottero, A.; Barreca, A.; Furlini, M.; Cesarone, A.; Ferrari, B.; Chrousos, G.P.; Bernasconi, S. Corticotropin- releasing hormone (CRH) inhibits steroid biosynthesis by cultured human granulosa-lutein cells in a CRH and interleukin-1 receptor-mediated fashion. Endocrinology, 1997, 138, 4806-4811 . (Pubitemid 27460918)
24. Mastorakos, G.; Scopa, C.D.; Vryonidou, A.; Friedman, T.C.; Kattis, D.; Phenekos, C.; Merino, M.J.; Chrousos, G.P. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J. Clin. Endocrinol. Metab., 1994, 79, 1191-1197.
25. Mastorakos, G.; Webster, E.L.; Friedman, T.C.; Chrousos, G.P. Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J. Clin. Invest., 1993, 92, 961-968 . (Pubitemid 23262420)
26. Calogero, A.E.; Burrello, N.; Negri-Cesi, P.; Papale, L.; Palumbo, M.A.; Cianci, A.; Sanfilippo, S.; D'Agata, R. Effects of corticotropin- releasing hormone on ovarian estrogen production in vitro. Endocrinology., 1996, 137, 4161-4166. (Pubitemid 26321861)
27. Chrousos, G.P.; Torpy, D.J.; Gold, P.W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann. Intern. Med., 1998, 129, 229-240.
28. Dufau, M.L.; Tinajero, J.C.; Fabbri, A. Corticotropin-releasing factor: an antireproductive hormone of the testis. FASEB J., 1993, 7, 299-307. (Pubitemid 23067780)
29. Zoumakis, E.; Chatzaki, E.; Charalampopoulos, I.; Margioris, A.N.; Angelakis, E.; Koumantakis, E.; Gravanis, A. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol. Endocrinol., 2001, 15, 98-102.
30. Florio, P.; Vale, W.; Petraglia, F. Urocortins in human reproduction. Peptides., 2004, 25, 1751-1757 .
31. Muramatsu, Y.; Sugino, N.; Suzuki, T.; Totsune, K.; Takahashi, K.; Tashiro, A.; Hongo, M.; Oki, Y.; Sasano, H. Urocortin and corticotropin- releasing factor receptor expression in normal cycling human ovaries. J. Clin. Endocrinol. Metab., 2001, 86, 1362-1369.
32. Yata, A.; Nakabayashi, K.; Wakahashi, S.; Maruo, N.; Ohara N.; Maruo, T. Suppression of progesterone production by stresscopin/ urocortin 3 in cultured human granulosa-lutein cells. Hum. Reprod., 2009, 24, 1748-1753.
33. Makrigiannakis, A.; Zoumakis, E.; Margioris, A.N.; Theodoropoulos, P.; Stournaras, C.; Gravanis, A. The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J. Clin. Endocrinol. Metab., 1995, 80, 185-189.
34. Makrigiannakis, A.; Zoumakis, E.; Margioris, A.N.; Stournaras, C.; Chrousos, G.P.; Gravanis, A. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology., 1996, 64, 85-92. (Pubitemid 26245262)
35. King, B.R.; Nicholson, R.C. Advances in understanding corticotrophin- releasing hormone gene expression. Front. Biosci., 2007, 12, 581-590.
36. Makrigiannakis, A.; Margioris, A.N.; Zoumakis, E.; Stournaras, C.; Gravanis, A. The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines. Neuroendocrinology., 1999, 70, 451-459. (Pubitemid 30009034)
37. Weitlauf, H.M. In The physiology of reproduction, E. Knobil, J. Neil, Eds.; New York:Raven Press: New York, 1988, pp. 231- 262.
38. Zoumakis, E.; Margioris, A.N.; Stournaras, C.; Dermitzaki, E.; Angelakis, E.; Makrigiannakis, A.; Koumantakis, E.; Gravanis, A. Corticotrophin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects the decidualization of human endometrial stroma. Mol. Hum. Reprod., 2000, 6, 344-351. (Pubitemid 30171522)
39. Torricelli, M.; De Falco, G.; Florio, P.; Rossi, M.; Leucci, E.; Viganò, P.; Leoncini, L.; Petraglia, F. Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum. Reprod., 2007, 22, 92-96. (Pubitemid 44942670)
40. Hatzoglou, A.; Gravanis, A.; Margioris, A.N.; Zoumakis, E.; Castanas, E. Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. J. Clin. Endocrinol. Metab., 1995, 80, 418-423.
41. Florio, P.; Torres, P.B.; Torricelli, M.; Toti, P.; Vale, W.; Petraglia, F. Human endometrium expresses urocortin II and III messenger RNA and peptides. Fertil. Steril., 2006, 86, 17661770. (Pubitemid 44778729)
42. Grino, M.; Chrousos, G.P.; Margioris, A.N. The corticotropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun., 1987, 148, 1208-1214. (Pubitemid 18074657)
43. McLean, M.; Bisits, A.; Davies, J.; Woods, R.; Lowry, P.; Smith, R. A placental clock controlling the length of human pregnancy. Nat. Med., 1995, 1, 460-463.
44. King, B.R.; Smith, R.; Nicholson, R.C. The regulation of human corticotrophin-releasing hormone gene expression in the placenta. Peptides, 2001, 22, 795-801. (Pubitemid 32397731)
45. Clifton, V.L.; Read, M.A.; Leitch, I.M.; Boura, A.L.; Robinson, P.J.; Smith, R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J. Clin. Endocrinol. Metab., 1994, 79, 666-669. (Pubitemid 24256572)
46. Stevens, M.Y.; Challis, J.R.; Lye, S.J. Corticotropin-releasing hormone receptor subtype 1 is significantly up-regulated at the time of labor in the human myometrium. J. Clin. Endocrinol. Metab., 1998, 83, 4107-4115.
47. Florio, P.; Zatelli, M.C.; Reis, F.M.; degli Uberti, E.C.; Petraglia, F. Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders? Front. Biosci., 2007, 12, 551-560.
48. Makrigiannakis, A.; Minas, V.; Kalantaridou, S.N.; Nikas, G.; Chrousos, G.P. Hormonal and cytokine regulation of early implantation. Trends. Endocrinol. Metab., 2006, 17, 178-185 .
49. Makrigiannakis, A.; Margioris, A.N.; Le Goascogne, C.; Zoumakis, E.; Nikas, G.; Stournaras, C.; Psychoyos, A.; Gravanis, A. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life. Sci., 1995, 57, 1869-1875.
50. Gill, T.J. Immunological and genetic factors influencing pregnancy and development. Am. J. Reprod. Immunol. Microbiol., 1986, 10, 116-120. (Pubitemid 16013782)
51. Lettau, M.; Paulsen, M.; Kabelitz, D.; Janssen, O. Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr. Med. Chem., 2008, 15, 1684-1696.
52. Makrigiannakis, A.; Zoumakis, E.; Kalantaridou, S.; Coutifaris, C.; Margioris, A.N.; Coukos, G.; Rice, K.C.; Gravanis, A.; Chrousos, G.P. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat. Immunol., 2001, 2, 1018-1024 .
53. Nagata, S. Apoptosis by death factor. Cell., 1997, 88, 355-365 .
54. Huang, D.C.; Hahne, M.; Schroeter, M.; Frei, K.; Fontana, A.; Villunger, A.; Newton, K.; Tschopp, J.; Strasser, A. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc. Natl. Acad. Sci. USA., 1999, 96, 14871-14876. (Pubitemid 30019732)
55. Lettau, M.; Paulsen, M.; Kabelitz, D.; Janssen, O. Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr. Med. Chem., 2008, 15, 1684-1696.
56. Kalantaridou, S.N.; Zoumakis, E.; Weil, S.; Lavasidis, L.G.; Chrousos, G.P.; Makrigiannakis, A. Reproductive corticotropin releasing hormone, implantation, and fetal immunotolerance. Crit. Rev. Clin. Lab Sci., 2007, 44, 461-481. (Pubitemid 47619400)
57. Muglia, L.; Jacobson, L.; Dikkes, P.; Majzoub, J.A. Corticotropin- releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature., 1995, 373, 427-432 .
58. Turnbull, A.V.; Smith, G.W.; Lee, S.; Vale, W.W.; Lee, K.F.; Rivier, C. CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology., 1999, 140, 1013-1017. (Pubitemid 29058244)
59. Minas, V.; Jeschke, U.; Kalantaridou, S.N.; Richter, D.U.; Reimer, T.; Mylonas, I.; Friese, K.; Makrigiannakis, A. Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin. Mol. Hum. Reprod., 2007, 13, 663-673 . (Pubitemid 47354914)
60. Bamberger, C.M.; Minas, V.; Bamberger, A.M.; Charalampopoulos, I.; Fragouli, Y.; Schulte, H.M.; Makrigiannakis, A. Expression of urocortin in the extravillous human trophoblast at the implantation site. Placenta., 2007, 28, 127-132 . (Pubitemid 44914533)
61. Petraglia, F.; Florio, P.; Benedetto, C.; Marozio, L.; Di Blasio, A.M.; Ticconi, C.; Piccione, E.; Luisi, S.; Genazzani, A.R.; Vale, W. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J. Clin. Endocrinol. Metab., 1999, 84, 1420-1423. (Pubitemid 30644409)
62. Florio, P.; Bruni, L.; De Falco, C.; Filardi, G.; Torricelli, M.; Reis, F.M.; Galleri, L.; Voltolini, C.; Bocchi, C.; De Leo, V.; Petraglia, F. Evaluation of endometrial urocortin secretion for prediction of pregnancy after intrauterine insemination. Clin. Chem., 2008, 54, 350-355. (Pubitemid 351302622)
63. Li, W.; Challis, J.R. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. J. Clin. Endocrinol. Metab., 2005, 90, 6569-6574.
64. Wakahashi, S.; Nakabayashi, K.; Maruo, N.; Yata, A.; Ohara, N.; Maruo, T. Effects of corticotropin-releasing hormone and stresscopin on vascular endothelial growth factor mRNA expression in cultured early human extravillous trophoblasts. Endocrinology, 2008, 33, 144-151 .
65. Imperatore, A.; Florio, P.; Torres, P.B.; Torricelli, M.; Galleri, L.; Toti, P.; Occhini, R.; Picciolini, E.; Vale, W.; Petraglia, F. Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. Am. J. Obstet. Gynecol., 2006, 195, 288-295. (Pubitemid 43927516)
66. Madhappan, B.; Kempuraj, D.; Christodoulou, S.; Tsapikidis, S.; Boucher, W.; Karagiannis, V.; Athanassiou, A.; Theoharides, T.C. High levels of intrauterine corticotropin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions. Endocrinology, 2003, 144, 2285-2290. (Pubitemid 36629879)